StockData
Solid Biosciences Inc. logo

Solid Biosciences Inc. (SLDB) income statement

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.25−0.19 (-2.95%)

Close on Nov 20, 2026Market cap $670.16MP/E –Yield –

See a number that looks wrong?